Table 2.

Association Between Risk Factors and M-Value

VariableT1D
T2D
P Valuea
Change in M-Value, % (95% CI)P ValueChange in M-Value, % (95% CI)P Value
Ageb−0.4 (−1.3 to 0.5)0.3780.3 (−0.6 to 1.2)0.4950.269
Female sexc−5.7 (−21.4 to 13.2)0.533−7.2 (−22.4 to 10.9)0.4130.898
Weight−0.3 (−1.8 to 1.1)0.6460.3 (−0.9 to 1.6)0.5890.462
BMIb−5.6 (−7.6 to −3.6)< 0.001d−4.6 (−6.6 to −2.6)< 0.001d0.470
Waist circumference−1.1 (−2.7 to 0.4)0.159−0.9 (−2.4 to 0.7)0.2800.870
WHRb−67.4 (−93.1 to 55.3)0.164−79.0 (−96.6 to 32.3)0.1020.674
Diabetes durationb−0.1 (−0.1 to 0.0)0.3040.0 (0.0 to 0.1)0.2690.131
Fasting glucoseb−4.8 (−7.8 to −1.6)0.005d−7.0 (−12.0 to −0.17)0.013d0.507
HbA1c, mmol/molb−0.57 (−1.11 to −0.02)0.047d−0.75 (−1.66 to 0.16)0.1130.746
HbA1c, %b−6.0 (−11.5 to −0.2)0.047d−7.9 (−16.5 to 1.8)0.1130.746
Triglyceridese,f−2.2 (−3.8 to −0.5)0.012d−1.7 (−2.9 to −0.4)0.011d0.633
HDLb,f16.7 (−7.4 to 47.2)0.19631.0 (−1.8 to 74.7)0.0710.475
LDLb,f4.7 (−5.4 to 15.9)0.377−3.9 (−12.0 to 5.0)0.3820.216
ASTe1.8 (−0.9 to 4.6)0.196−0.3 (−2.4 to 1.8)0.7650.224
ALTe0.4 (−1.6 to 2.4)0.703−1.0 (−2.4 to 0.4)0.1610.275
GGTe0.01 (−1.5 to 1.5)0.989−1.5 (−2.8 to −0.1)0.047d0.176
CRPe−0.7 (−1.5 to 0.1)0.078−0.7 (−1.6 to 0.1)0.1050.982
IL-6e−0.1 (−1.3 to 1.1)0.881−0.5 (−1.6 to 0.6)0.3680.673
Total adiponectine0.5 (−2.1 to 3.2)0.8812.9 (0.6 to 5.1)0.015d0.171
HMW adiponectine0.6 (−1.0 to 2.3)0.4721.8 (0.1 to 3.4)0.039d0.240
HMW/total adiponectin ratioe1.7 (−1.6 to 5.1)0.3181.7 (−2.5 to 6.0)0.4470.771
VariableT1D
T2D
P Valuea
Change in M-Value, % (95% CI)P ValueChange in M-Value, % (95% CI)P Value
Ageb−0.4 (−1.3 to 0.5)0.3780.3 (−0.6 to 1.2)0.4950.269
Female sexc−5.7 (−21.4 to 13.2)0.533−7.2 (−22.4 to 10.9)0.4130.898
Weight−0.3 (−1.8 to 1.1)0.6460.3 (−0.9 to 1.6)0.5890.462
BMIb−5.6 (−7.6 to −3.6)< 0.001d−4.6 (−6.6 to −2.6)< 0.001d0.470
Waist circumference−1.1 (−2.7 to 0.4)0.159−0.9 (−2.4 to 0.7)0.2800.870
WHRb−67.4 (−93.1 to 55.3)0.164−79.0 (−96.6 to 32.3)0.1020.674
Diabetes durationb−0.1 (−0.1 to 0.0)0.3040.0 (0.0 to 0.1)0.2690.131
Fasting glucoseb−4.8 (−7.8 to −1.6)0.005d−7.0 (−12.0 to −0.17)0.013d0.507
HbA1c, mmol/molb−0.57 (−1.11 to −0.02)0.047d−0.75 (−1.66 to 0.16)0.1130.746
HbA1c, %b−6.0 (−11.5 to −0.2)0.047d−7.9 (−16.5 to 1.8)0.1130.746
Triglyceridese,f−2.2 (−3.8 to −0.5)0.012d−1.7 (−2.9 to −0.4)0.011d0.633
HDLb,f16.7 (−7.4 to 47.2)0.19631.0 (−1.8 to 74.7)0.0710.475
LDLb,f4.7 (−5.4 to 15.9)0.377−3.9 (−12.0 to 5.0)0.3820.216
ASTe1.8 (−0.9 to 4.6)0.196−0.3 (−2.4 to 1.8)0.7650.224
ALTe0.4 (−1.6 to 2.4)0.703−1.0 (−2.4 to 0.4)0.1610.275
GGTe0.01 (−1.5 to 1.5)0.989−1.5 (−2.8 to −0.1)0.047d0.176
CRPe−0.7 (−1.5 to 0.1)0.078−0.7 (−1.6 to 0.1)0.1050.982
IL-6e−0.1 (−1.3 to 1.1)0.881−0.5 (−1.6 to 0.6)0.3680.673
Total adiponectine0.5 (−2.1 to 3.2)0.8812.9 (0.6 to 5.1)0.015d0.171
HMW adiponectine0.6 (−1.0 to 2.3)0.4721.8 (0.1 to 3.4)0.039d0.240
HMW/total adiponectin ratioe1.7 (−1.6 to 5.1)0.3181.7 (−2.5 to 6.0)0.4470.771

Multiple linear regression models adjusted for age, sex, and BMI.

a

P value for difference of relative change in M-value between T1D and T2D.

b

Relative change in M-value (%) for a one-unit increase of an independent variable. 
cRelative change in M-value (%) compared with men.

d

Statistically significant.

e

Relative change in M-value (%) for a 10%-change in the independent variable.

f

Also adjusted for lipid-lowering agents.

Table 2.

Association Between Risk Factors and M-Value

VariableT1D
T2D
P Valuea
Change in M-Value, % (95% CI)P ValueChange in M-Value, % (95% CI)P Value
Ageb−0.4 (−1.3 to 0.5)0.3780.3 (−0.6 to 1.2)0.4950.269
Female sexc−5.7 (−21.4 to 13.2)0.533−7.2 (−22.4 to 10.9)0.4130.898
Weight−0.3 (−1.8 to 1.1)0.6460.3 (−0.9 to 1.6)0.5890.462
BMIb−5.6 (−7.6 to −3.6)< 0.001d−4.6 (−6.6 to −2.6)< 0.001d0.470
Waist circumference−1.1 (−2.7 to 0.4)0.159−0.9 (−2.4 to 0.7)0.2800.870
WHRb−67.4 (−93.1 to 55.3)0.164−79.0 (−96.6 to 32.3)0.1020.674
Diabetes durationb−0.1 (−0.1 to 0.0)0.3040.0 (0.0 to 0.1)0.2690.131
Fasting glucoseb−4.8 (−7.8 to −1.6)0.005d−7.0 (−12.0 to −0.17)0.013d0.507
HbA1c, mmol/molb−0.57 (−1.11 to −0.02)0.047d−0.75 (−1.66 to 0.16)0.1130.746
HbA1c, %b−6.0 (−11.5 to −0.2)0.047d−7.9 (−16.5 to 1.8)0.1130.746
Triglyceridese,f−2.2 (−3.8 to −0.5)0.012d−1.7 (−2.9 to −0.4)0.011d0.633
HDLb,f16.7 (−7.4 to 47.2)0.19631.0 (−1.8 to 74.7)0.0710.475
LDLb,f4.7 (−5.4 to 15.9)0.377−3.9 (−12.0 to 5.0)0.3820.216
ASTe1.8 (−0.9 to 4.6)0.196−0.3 (−2.4 to 1.8)0.7650.224
ALTe0.4 (−1.6 to 2.4)0.703−1.0 (−2.4 to 0.4)0.1610.275
GGTe0.01 (−1.5 to 1.5)0.989−1.5 (−2.8 to −0.1)0.047d0.176
CRPe−0.7 (−1.5 to 0.1)0.078−0.7 (−1.6 to 0.1)0.1050.982
IL-6e−0.1 (−1.3 to 1.1)0.881−0.5 (−1.6 to 0.6)0.3680.673
Total adiponectine0.5 (−2.1 to 3.2)0.8812.9 (0.6 to 5.1)0.015d0.171
HMW adiponectine0.6 (−1.0 to 2.3)0.4721.8 (0.1 to 3.4)0.039d0.240
HMW/total adiponectin ratioe1.7 (−1.6 to 5.1)0.3181.7 (−2.5 to 6.0)0.4470.771
VariableT1D
T2D
P Valuea
Change in M-Value, % (95% CI)P ValueChange in M-Value, % (95% CI)P Value
Ageb−0.4 (−1.3 to 0.5)0.3780.3 (−0.6 to 1.2)0.4950.269
Female sexc−5.7 (−21.4 to 13.2)0.533−7.2 (−22.4 to 10.9)0.4130.898
Weight−0.3 (−1.8 to 1.1)0.6460.3 (−0.9 to 1.6)0.5890.462
BMIb−5.6 (−7.6 to −3.6)< 0.001d−4.6 (−6.6 to −2.6)< 0.001d0.470
Waist circumference−1.1 (−2.7 to 0.4)0.159−0.9 (−2.4 to 0.7)0.2800.870
WHRb−67.4 (−93.1 to 55.3)0.164−79.0 (−96.6 to 32.3)0.1020.674
Diabetes durationb−0.1 (−0.1 to 0.0)0.3040.0 (0.0 to 0.1)0.2690.131
Fasting glucoseb−4.8 (−7.8 to −1.6)0.005d−7.0 (−12.0 to −0.17)0.013d0.507
HbA1c, mmol/molb−0.57 (−1.11 to −0.02)0.047d−0.75 (−1.66 to 0.16)0.1130.746
HbA1c, %b−6.0 (−11.5 to −0.2)0.047d−7.9 (−16.5 to 1.8)0.1130.746
Triglyceridese,f−2.2 (−3.8 to −0.5)0.012d−1.7 (−2.9 to −0.4)0.011d0.633
HDLb,f16.7 (−7.4 to 47.2)0.19631.0 (−1.8 to 74.7)0.0710.475
LDLb,f4.7 (−5.4 to 15.9)0.377−3.9 (−12.0 to 5.0)0.3820.216
ASTe1.8 (−0.9 to 4.6)0.196−0.3 (−2.4 to 1.8)0.7650.224
ALTe0.4 (−1.6 to 2.4)0.703−1.0 (−2.4 to 0.4)0.1610.275
GGTe0.01 (−1.5 to 1.5)0.989−1.5 (−2.8 to −0.1)0.047d0.176
CRPe−0.7 (−1.5 to 0.1)0.078−0.7 (−1.6 to 0.1)0.1050.982
IL-6e−0.1 (−1.3 to 1.1)0.881−0.5 (−1.6 to 0.6)0.3680.673
Total adiponectine0.5 (−2.1 to 3.2)0.8812.9 (0.6 to 5.1)0.015d0.171
HMW adiponectine0.6 (−1.0 to 2.3)0.4721.8 (0.1 to 3.4)0.039d0.240
HMW/total adiponectin ratioe1.7 (−1.6 to 5.1)0.3181.7 (−2.5 to 6.0)0.4470.771

Multiple linear regression models adjusted for age, sex, and BMI.

a

P value for difference of relative change in M-value between T1D and T2D.

b

Relative change in M-value (%) for a one-unit increase of an independent variable. 
cRelative change in M-value (%) compared with men.

d

Statistically significant.

e

Relative change in M-value (%) for a 10%-change in the independent variable.

f

Also adjusted for lipid-lowering agents.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close